InBody Co.Ltd (041830) — Capital Reinvestment Ratio
Latest as of September 2025:
0.40x
InBody Co.Ltd (041830) has a Capital Reinvestment Ratio of 0.40x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩9.04 Billion) in capital expenditures (₩3.64 Billion). See how much free cash does InBody Co.Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.40x
Capex / Operating Cash Flow
Operating Cash Flow
₩9.04 Billion
KRW
Capital Expenditures
₩3.64 Billion
KRW
Data as of
Sep 2025
Most recent filing
InBody Co.Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks InBody Co.Ltd's Capital Reinvestment Ratio across 14 annual periods.
Annual Capital Reinvestment Ratio for InBody Co.Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for InBody Co.Ltd from 2011 to 2024. For live market cap and broader valuation context, see market value of InBody Co.Ltd.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.26x | ₩28.58 Billion | ₩7.55 Billion | ▲ +33.8% |
| 2023 | 0.20x | ₩38.69 Billion | ₩7.64 Billion | ▼ -0.1% |
| 2022 | 0.20x | ₩30.42 Billion | ₩6.02 Billion | ▼ -47.6% |
| 2021 | 0.38x | ₩30.35 Billion | ₩11.45 Billion | ▲ +537.4% |
| 2020 | 0.06x | ₩28.50 Billion | ₩1.69 Billion | ▼ -53.4% |
| 2019 | 0.13x | ₩24.21 Billion | ₩3.08 Billion | ▼ -94.5% |
| 2018 | 2.31x | ₩17.70 Billion | ₩40.86 Billion | ▲ +707.1% |
| 2017 | 0.29x | ₩18.58 Billion | ₩5.31 Billion | ▼ -37.9% |
| 2016 | 0.46x | ₩18.24 Billion | ₩8.41 Billion | ▼ -31.8% |
| 2015 | 0.68x | ₩11.18 Billion | ₩7.55 Billion | ▲ +372.3% |
| 2014 | 0.14x | ₩10.26 Billion | ₩1.47 Billion | ▼ -89.2% |
| 2013 | 1.32x | ₩6.99 Billion | ₩9.26 Billion | ▲ +609.8% |
| 2012 | 0.19x | ₩4.36 Billion | ₩812.05 Million | ▼ -57.4% |
| 2011 | 0.44x | ₩5.50 Billion | ₩2.41 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow